COVID-19: the use of immunotherapy in metastatic lung cancer

Alexander P. Davis, Michael Boyer, Jenny H. Lee, Steven C. Kao*

*Corresponding author for this work

    Research output: Contribution to journalComment/opinionpeer-review

    16 Citations (Scopus)
    Original languageEnglish
    Pages (from-to)545-548
    Number of pages4
    JournalImmunotherapy
    Volume12
    Issue number8
    DOIs
    Publication statusPublished - Jun 2020

    Keywords

    • COVID-19
    • duration of therapy
    • immune checkpoint inhibitors
    • immunotherapy
    • lung cancer

    Cite this